Phase 3 multicenter randomized trial of PSMA PET/CT prior to definitive radiation therapy for unfavorable intermediate-risk or high-risk prostate cancer [PSMA dRT]: Study Protocol.

被引：0
|
作者：
Calais, Jeremie [1 ]
Zhu, Shaojun [1 ]
Hrimas, Nader [2 ]
Eiber, Matthias [3 ]
Hadaschik, Boris [2 ]
Stuschke, Martin [2 ]
Herrmann, Ken [2 ]
Czernin, Johannes [1 ]
Kishan, Amar U. [1 ]
Nickols, Nicholas G. [1 ]
Elashoff, David [1 ]
Fendler, Wolfgang [2 ]
机构：
[1] Univ Calif Los Angeles, Los Angeles, CA USA
[2] Univ Essen Gesamthsch, Essen, Germany
[3] TUM, Munich, Germany
来源：
CANCER RESEARCH | 2021年 / 81卷 / 13期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
CT257
引用
收藏
页数：2
相关论文
共 50 条
  • [21] PSMA-density predicts pathological and oncological outcomes in patients submitted to 18F-PSMA-1007 PET/CT for the primary staging of unfavorable intermediate and high-risk prostate cancer
    Donegani, M.
    Ambrosini, F.
    Mantica, G.
    Piol, N.
    Miceli, A.
    D'Amico, F.
    Riondato, M.
    Di Raimondo, T.
    Lanfranchi, F.
    Raffa, S.
    Chiola, S.
    Spina, B.
    Suardi, N.
    Morbelli, S.
    Borghesi, M.
    Nozza, P.
    Fiocca, R.
    Sambuceti, G.
    Terrone, C.
    Bauckneht, M.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2022, 49 (SUPPL 1) : S218 - S218
  • [22] Ga 68 PSMA PET/CT at the initial staging of high-risk patients with prostate cancer
    Pipikos, T.
    Vogiatzis, M.
    Andreou, J.
    Kechagias, D.
    Fillipi, V.
    Oikonomou, E.
    Gogos, K.
    Merisoglou, S.
    Papoutsani, D.
    Dalianis, K.
    Efthimiadou, R.
    Prassopoulos, V.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2021, 48 (SUPPL 1) : S453 - S454
  • [23] National Uruguayan Experience with PSMA PET/CT in Initial Staging in High-risk prostate cancer
    dos Santos, Gerardo
    Banchero, Agustina
    Quagliata, Adriana
    Niell, Nicolas
    Cordero, Ismael
    Giglio, Javier
    Trindade, Victoria
    Leiva, Juan
    Rodriguez, Sergio
    Sanchez, Aldo
    Savio, Eduardo
    Duarte, Pablo
    Gambini, Juan
    Alonso, Omar
    JOURNAL OF NUCLEAR MEDICINE, 2024, 65
  • [24] Comparison of 18F-PSMA-1007 PET/CT With 68Ga-PSMA-11 PET/CT for Initial Staging in Intermediate- and High-Risk Prostate Cancer
    Chandekar, Kunal Ramesh
    Singh, Harmandeep
    Kumar, Rajender
    Kumar, Santosh
    Kakkar, Nandita
    Mittal, Bhagwant Rai
    Singh, Shrawan Kumar
    CLINICAL NUCLEAR MEDICINE, 2023, 48 (01) : E1 - E8
  • [25] Immunohistochemical PSMA Expression and Histology Predictors in Primary Staging High-risk Prostate Cancer Patients Studied with PSMA PET/CT: a PSMA Expression Investigation
    Vetrone, L.
    Mei, R.
    Farolfi, A.
    Bianchi, L.
    Giunchi, F.
    De Giovanni, A.
    Calderoni, L.
    Serani, F.
    Costa, F.
    Pissavini, A.
    Schiavina, R.
    Brunocilla, E.
    Castellucci, P.
    Fanti, S.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2022, 49 (SUPPL 1) : S403 - S404
  • [26] 68Ga-PSMA-11 PET/MRI in Primary Intermediate/High-Risk Prostate Cancer
    Park, S.
    Zacharias, C.
    Harrison, C.
    Baratto, L.
    Hatami, N.
    Iagaru, A.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2017, 44 : S709 - S710
  • [27] 68Ga-PSMA-11 PET/MRI in Primary Intermediate/High-Risk Prostate Cancer
    Park, Sonya
    Zacharias, Claudia
    Harrison, Caitlyn
    Giesel, Frederik
    Iagaru, Andrei
    JOURNAL OF NUCLEAR MEDICINE, 2018, 59
  • [28] PSMA PET/CT guided intensification of therapy in patients at risk of advanced prostate cancer (PATRON): a pragmatic phase III randomized controlled trial
    Cynthia Ménard
    Sympascho Young
    Katherine Zukotynski
    Robert J. Hamilton
    François Bénard
    Steven Yip
    Christopher McCabe
    Fred Saad
    Michael Brundage
    Roy Nitulescu
    Glenn Bauman
    BMC Cancer, 22
  • [29] PSMA-targeted PET with [68Ga]Ga-P16-093: Initial evaluation in intermediate-risk and high-risk prostate cancer patients prior to prostatectomy
    Green, Mark
    Bahler, Clint
    Tann, Mark
    Hutchins, Gary
    Mathias, Carla
    Territo, Wendy
    Whaley, Rumeal
    Cheng, Liang
    Alexoff, David
    Eckelman, William
    Kung, Hank
    JOURNAL OF NUCLEAR MEDICINE, 2020, 61
  • [30] PSMA PET/CT guided intensification of therapy in patients at risk of advanced prostate cancer (PATRON): a pragmatic phase III randomized controlled trial
    Menard, Cynthia
    Young, Sympascho
    Zukotynski, Katherine
    Hamilton, Robert J.
    Benard, Francois
    Yip, Steven
    McCabe, Christopher
    Saad, Fred
    Brundage, Michael
    Nitulescu, Roy
    Bauman, Glenn
    BMC CANCER, 2022, 22 (01)
12345